PRIME status for Adaptimmune’s synovial sarcoma drug by Selina McKee | Jul 28, 2020 | News | 0 The drug has the potential to address an unmet need Read More
Adaptimmune, MSD to test multiple myeloma combo by Selina McKee | Oct 31, 2016 | News | 0 Oxford, UK-based Adaptimmune has formed a clinical trial pact with MSD to test a potential new combination therapy for multiple myeloma. Read More